Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials

QR Code

Memantine treatment for Japanese patients with moderate to severe Alzheimer’s disease: a meta-analysis of double-blind, randomized, placebo-controlled trials

Taro Kishi,1,* Shinji Matsunaga,1,2,* Nakao Iwata1 1Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan; 2Department of Geriatrics and Cognitive Disorders, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan *These authors c...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Kishi T, Matsunaga S, Iwata N
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2018
Sujets:	Japanese patients Alzheimer’s disease memantine cognitive functions behavioral disturbances meta-analysis Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/3ec67a78498f4e618110e3ad6effe6c1
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

The effects of memantine on behavioral disturbances in patients with Alzheimer's disease: a meta-analysis
par: Kishi T, et autres
Publié: (2017)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
par: Stuart J Thomas, et autres
Publié: (2009)

Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trial
par: Wade AG, et autres
Publié: (2014)

Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
par: Kishi T, et autres
Publié: (2017)

Memantine for the treatment of frontotemporal dementia: a meta-analysis
par: Kishi T, et autres
Publié: (2015)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
par: Ben Seltzer
Publié: (2009)

The Effect of Oxidative Stress and Memantine-Incorporated Reactive Oxygen Species-Sensitive Nanoparticles on the Expression of <i>N</i>-Methyl-<span style="font-variant: small-caps">d</span>-aspartate Receptor Subunit 1 in Brain Cancer Cells for Alzheimer’s Disease Application
par: Jung Sun Park, et autres
Publié: (2021)

Memantine induces manic episode in a 73-year-old patient with vascular neurocognitive disorder: a case report
par: Duan JF, et autres
Publié: (2018)

Estrogen receptor α gene polymorphisms and risk of Alzheimer’s disease: evidence from a meta-analysis
par: Cheng D, et autres
Publié: (2014)

Identification of the optimal cognitive drugs among Alzheimer’s disease: a Bayesian meta-analytic review
par: Liang JH, et autres
Publié: (2018)

Update on the use of memantine in Alzheimer&rsquo;s disease
par: Robert J van Marum
Publié: (2009)

Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer&rsquo;s disease
par: Umamon Puangthong, et autres
Publié: (2009)

Different durations of cognitive stimulation therapy for Alzheimer’s disease: a systematic review and meta-analysis
par: Chen J, et autres
Publié: (2019)

A SENSITIVE SEQUENTIAL INJECTION ANALYSIS (SIA) DETERMINATION OF MEMANTINE HYDROCHLORIDE USING LUMINOL-HYDROGEN PEROXIDE INDUCED CHEMILUMINESCENCE DETECTION
par: ALARFAJ,NAWAL A, et autres
Publié: (2014)

Melatonin receptor agonists—ramelteon and melatonin—for bipolar disorder: a systematic review and meta-analysis of double-blind, randomized, placebo-controlled trials
par: Kishi T, et autres
Publié: (2019)

Association of interleukin-33 gene polymorphisms with susceptibility to late onset Alzheimer’s disease: a meta-analysis
par: Zhong X, et autres
Publié: (2017)

Cost-effectiveness analysis of memantine for moderate-to-severe Alzheimer&#39;s disease in the Netherlands
par: Hoogveldt B, et autres
Publié: (2011)

The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study
par: Yatawara C, et autres
Publié: (2021)

Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial.
par: Chris Fox, et autres
Publié: (2012)

Effect of Curcumin on Beta-Amyloid Plasma Level in Alzheimer Disease: A Systematic Review and Meta-analysis
par: Shima Mehrabadi, et autres
Publié: (2021)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
par: Yuan J, et autres
Publié: (2013)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
par: Klimova B, et autres
Publié: (2017)

Olfactory dysfunction in Alzheimer’s disease
par: Zou YM, et autres
Publié: (2016)

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
par: Muratli S, et autres
Publié: (2015)

Alzheimer's research & therapy
Publié: (2009)

11C-PIB PET imaging reveals that amyloid deposition in cases with early-onset Alzheimer’s disease in the absence of known mutations retains higher levels of PIB in the basal ganglia
par: Youn YC, et autres
Publié: (2017)

Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
par: Sumirtanurdin R, et autres
Publié: (2019)

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials
par: Kishi T, et autres
Publié: (2018)

Drug therapies and presence of coronary artery disease may affect aortic stiffness in Alzheimer’s disease
par: Bektaş O, et autres
Publié: (2015)

Cytological and cytometric analysis of oral mucosa in patients with Alzheimer’s and Parkinson’s disease
par: Kose Ozlece H, et autres
Publié: (2018)

Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
par: Li XH, et autres
Publié: (2015)

Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
par: Cai Y, et autres
Publié: (2015)

Journal of Alzheimer's disease
Publié: (1998)

Spaced Retrieval and Episodic Memory Training in Alzheimer’s Disease
par: Small JA, et autres
Publié: (2020)

A genetic screen of the mutations in the Korean patients with early-onset Alzheimer’s disease
par: An SS, et autres
Publié: (2016)

Baicalein improves behavioral dysfunction induced by Alzheimer’s disease in rats
par: Zhou L, et autres
Publié: (2016)

Patient characteristics associated with screening positive for Alzheimer’s disease and related dementia
par: Fowler NR, et autres
Publié: (2018)

Effect of the Casein-Derived Peptide Met-Lys-Pro on Cognitive Function in Community-Dwelling Adults Without Dementia: A Randomized, Double-Blind, Placebo-Controlled Trial
par: Yuda N, et autres
Publié: (2020)

Feasibility and efficacy of cognitive telerehabilitation in early Alzheimer’s disease: a pilot study
par: Jelcic N, et autres
Publié: (2014)

Circulating Glutamine and Alzheimer’s Disease: A Mendelian Randomization Study
par: Adams CD
Publié: (2020)